BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Diagnosis
55 results:

  • 1. Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma.
    Jiang A; Ye J; Zhou Y; Zhu B; Lu J; Ge S; Qu L; Xiao J; Wang L; Cai C
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766692
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma.
    Takezawa Y; Izumi K; Shimura Y; Aerken M; Natsagdorji A; Iijima M; Shigehara K; Nohara T; Narimoto K; Kadono Y; Kitagawa Y; Konaka H; Mizokami A
    Anticancer Res; 2016 Sep; 36(9):4961-4. PubMed ID: 27630356
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.
    Merriman J; Tward J; Albertson D; Dechet C; Agarwal N
    J Immunother; 2016; 39(2):101-3. PubMed ID: 26849079
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Interleukin 2 as a potential cancer marker in patients after kidney transplantation.
    Witkowska A; Zywiec J; Strozik A; Gorczynska-Kosiorz S; Trautsolt W; Strzalka-Mrozik B; Kimsa M; Owczarek A; Stępień B; Mazurek U; Grzeszczak W; Gumprecht J
    Ann Agric Environ Med; 2015; 22(2):320-4. PubMed ID: 26094531
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SEOM clinical guidelines for the treatment of renal cell carcinoma.
    Bellmunt J; Puente J; Garcia de Muro J; Lainez N; Rodríguez C; Duran I;
    Clin Transl Oncol; 2014 Dec; 16(12):1043-50. PubMed ID: 25274276
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience.
    Birkhäuser FD; Pantuck AJ; Rampersaud EN; Wang X; Kroeger N; Pouliot F; Zomorodian N; Riss J; Li G; Kabbinavar FF; Belldegrun AS
    Cancer J; 2013; 19(3):189-96. PubMed ID: 23708063
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10.
    Erinjeri JP; Thomas CT; Samoilia A; Fleisher M; Gonen M; Sofocleous CT; Thornton RH; Siegelbaum RH; Covey AM; Brody LA; Alago W; Maybody M; Brown KT; Getrajdman GI; Solomon SB
    J Vasc Interv Radiol; 2013 Aug; 24(8):1105-12. PubMed ID: 23582441
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Results of targeted therapies for m1 renal cell carcinoma: our experience].
    Legramanti S; Antonelli A; Ferrari V; Arrighi N; Corti S; Zanotelli T; Ozzoli A; Cosciani Cunico S; Simeone C
    Urologia; 2012 Dec; 79 Suppl 19():72-5. PubMed ID: 23371277
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Case of intravascular lymphoma with a longitudinal spinal lesion diagnosed by multiple biopsies].
    Shirai S; Takahashi I; Kanoh T; Sato K; Kubota KC; Yabe I; Murayama S; Sasaki H
    Rinsho Shinkeigaku; 2012; 52(5):336-43. PubMed ID: 22688113
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
    Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Perek-Polnik M; Kurylak A; Pietras W; Kuzmicz M; Mizia-Malarz A; Rybczynska A; Nurzynska-Flak J
    Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
    Miyake H; Sakai I; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M
    Int J Urol; 2009 May; 16(5):465-71. PubMed ID: 19467119
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pathology of renal tumors in adults. Molecular biology, histopathological diagnosis and prognosis.
    Okoń K
    Pol J Pathol; 2008; 59(3):129-76. PubMed ID: 19097356
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature.
    Del Monte G; Ferroni P; Mariotti S; Fossile E; Guadagni F; Roselli M
    In Vivo; 2008; 22(4):481-8. PubMed ID: 18712176
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunotherapy for renal cell cancer in the era of targeted therapy.
    Coppin C
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):907-19. PubMed ID: 18533800
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A case of renal cell carcinoma with multiple lung metastases refractory to interferon-alpha showing complete remission by interleukin-2 monotherapy.
    Hayashi T; Miyagawa Y; Tsujimura A; Nonomura N; Minami M; Okuyama A
    Int J Urol; 2006 Jun; 13(6):805-8. PubMed ID: 16834666
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Implications of therapy choice on overall survival in metastatic renal cell carcinoma: a single institution experience.
    Parmar S; Rademaker AW; Fung BB; Kozlowski JM; Kuzel TM
    Med Oncol; 2005; 22(4):399-405. PubMed ID: 16260858
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report.
    Tokunaga M; Masuda A; Mukai M; Nakamura H; Iwaki K; Terachi T
    Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.